Session

  • Title : RF Microneedling: Key Insights
  • Thermage Room : Level 2, Grand Ballroom, Convention Center
  • Time : 09:00 - 10:30

Chair

Hyunchul Sung South Korea

Chao-Chin Wang Taiwan

Lecture & Speaker

HoursSpeakersTitle
09:00 - 09:15 Jack Jeng-Feng Chen

How non-insulated microneedle radiofrequency device revolutionized clinical practice: exploring diverse applications and transf

In the rapidly evolving landscape of aesthetic and medical dermatology, non-insulated microneedle radiofrequency (RF) devices have emerged as a groundbreaking tool, revolutionizing clinical practice. This presentation, titled "How Non-insulated Microneedle Radiofrequency Device Revolutionized Clinical Practice: Exploring Diverse Applications and Transformative Outcomes," will provide an in-depth examination of this innovative technology and its wide-ranging applications.<br/><br/>Attendees will learn about the mechanics of non-insulated microneedle RF, which combines the benefits of microneedling with controlled RF energy to enhance skin rejuvenation, tighten tissue, and address a variety of skin concerns, including melasma, acne scars, pores and wrinkles. We will explore the device's versatility, discussing its efficacy in treating different skin types and conditions.<br/><br/>Through case studies and clinical outcomes, this presentation will highlight the transformative results achievable with this technique, emphasizing patient satisfaction and minimal downtime. Join us to discover how non-insulated microneedle RF is setting new standards in aesthetic treatment, empowering clinicians to deliver exceptional care and enhance patient outcomes.

09:15 - 09:30 Ayaka Nishikawa

Optimizing skin rejuvenation treatment in asian patients with RF microneedling

Microneedle RF has emerged as an innovative approach to melasma and was introduced at our facility in 2019, with a cumulative experience of 131,523 cases by August 2024. Focusing on the multi-short pulses (PW: Pulsed Wave) that selectively produce thermal coagulation in the basement membrane and blood vessels, we have reported on the effectiveness and safety of melasma and skin rejuvenation treatment with this device at the conference. This time, we will show that by using the single long pulse (CW: Continuous Wave) that produces thermal coagulation in all layers of the skin and PW, which are equipped in this device, it is possible to approach not only melasma and skin rejuvenation but a wide range of conditions such as redness, wrinkle lines, pores, acne, and acne scars. We will show that it can be used for a wide range of conditions. Twenty patients (18 female and 2 male) with an average age of 38.4 (27-53) years were treated with pulsed oscillating needle RF every 2-4 weeks for 5 sessions. The NRS was measured as an assessment of pain and the VAS as a measure of treatment satisfaction. Photographs were recorded at each treatment session using a skin analysis device (VISIA®Evolution, Canfield Scientific, USA) for objective evaluation of efficacy and adverse events, and the final determination of treatment efficacy was made 3 months after the last irradiation date. We will report the results with a literature review.<br/>As a chain of clinics, it is important for us to standardize equipment settings and irradiation techniques. While it is interesting that a single device can be used to achieve a variety of therapeutic effects, we are trying to standardize protocols for a wide range of indications. We would like to present the current status of protocols in 2024, which are continuously being updated to make patients and surgeons more comfortable.

09:30 - 09:45 Chao-Chin Wang

Beyond the hype- Revealing the truth behind microneedle RF

Comming Soon

09:45 - 10:00 Che-hao Hsu

In vivo observation of thermo-mechanical ablation and radio frequency microneedling with optical coherence tomography

This study explores the in vivo observation of Thermo-Mechanical Ablation (TMA) and Radio Frequency Microneedling (RFMN) techniques, utilizing Optical Coherence Tomography (OCT) as an imaging modality. TMA and RFMN are innovative dermatological treatments aimed at skin rejuvenation and scar reduction. The research employs OCT to visualize and assess the tissue response and morphological changes post-treatment in real-time, providing insights into the efficacy and safety of these procedures. This investigation paves the way for further understanding of the underlying mechanisms of TMA and RFMN, ultimately contributing to improved clinical practices in dermatology.

10:00 - 10:15 Michael H. Gold

Microneedling RF in 2024 – what have we learned

Objectives: The objectives of thus presentation is to demonstrate the new concepts in microneedling RF technology.<br/>Introduction: Microneedling with RF needles has become a very popular modality for treating wrinkles, photodamaged skin, and atrophic acne or traumatic scars. Many of the EBD companies have developed microneedling RF devices that use either insulated or non-insulated needles and use fractional or stamp delivery of the needles into the skin. <br/>Methods: The different devices that are available now will be reviewed with the evidence-based medicine to support their effectiveness and their safety. In addition, some new novel devices will also be discussed and how they fit into this group of devices.<br/>Results and Conclusions: This class of device for cosmetic practices has become very important and from this presentation, how they work, why they work, and how well they work will be reviewed.

Speaker

Jack Jeng-Feng Chen

Beaute J'adore Dermatological and Aesthetic Clinic
Taiwan

Curriculum Vitae

Dr. Jeng-Feng Chen is a highly qualified dermatologist and aesthetic physician from Taiwan, with extensive training from the National Defense Medical Center and a residency in dermatology at Tri-Service General Hospital. He has held various prestigious positions, including attending physician and consulting dermatologist, and is currently at Beauté J'adore Dermatology and Aesthetic Clinic. Dr. Chen is a member of multiple professional societies and holds board certifications in dermatology and cosmetic dermatology. He has published numerous research articles and served as a speaker and trainer for leading pharmaceutical companies, specializing in cosmetic dermatology, including energy-based devices and injectables.

Ayaka Nishikawa

Shonan Beauty Clinic
Japan

Curriculum Vitae

Dr. Ayaka Nishikawa obtained her M.D. from Yokohama City University School of Medicine in Japan in 2013. Following her graduation, she completed her professional training at Tokyo Medical Center in 2015. Since then, she has been dedicated to her practice at Shonan Beauty Clinic in Japan, where she assumed the role of Manager of the Dermatology Department in 2017. Currently, Dr. Nishikawa serves as the Director of the Dermatology Department at Shonan Beauty Clinic and holds a position as a Visiting Professor at SBC Tokyo Medical University. Dr. Nishikawa is highly regarded both locally and internationally as a speaker, focusing on Asian skin rejuvenation and body contouring techniques employing injectables and energy-based devices. She actively engages in educating and mentoring over 400 doctors in her field.

Chao-Chin Wang

Vigor Clinics, Kaohsiung Liberal and Tainan Office
Taiwan

Curriculum Vitae

Che-hao Hsu

Hao-Skin Dermatologic and Cosmetic Clinic
Taiwan

Curriculum Vitae

Director, Hao-Skin Dermatologic and Cosmetic Clinic Direcror, Taiwan Society for Dermatological and Aesthetic Surgery Director, Laser and Photonics Medicine Society of Taiwan Director, Taiwan Association of Aesthetic Plastic Surgery Deputy Secretary-general, Chinese Society of Cosmetic Surgery and Anti-aging Medicine Reviewer for Journal of Cosmetic Dermatology

Michael H. Gold

Gold Skin Care Center, Tennessee Clinical Research Center
United States

Curriculum Vitae

Dr. Michael H. Gold is the founder and medical director of Gold Skin Care Center, Advanced Aesthetics Medical Spa, The Laser & Rejuvenation Center, and Tennessee Clinical Research Center in Nashville, TN. He is a board-certified dermatologist and dermatologic surgeon and oversees the various facets of the center's operations — a combination of medical and surgical dermatology, cosmetic dermatology, aesthetic services and research endeavors, which began in 1990. The Tennessee Clinical Research Center is regarded in the industry as one of the best clinical research centers for medical dermatology and aesthetic/cosmetic research endeavors – focusing on FDA Phase II, III, and IV clinical trials. Dr. Gold has earned worldwide recognition for providing patients with leading-edge technological advances in dermatology and aesthetic skin care. He plays an integral role in the development of new pharmaceutical products, injectable fillers and toxins, skin care, and medical devices through his clinical research practice. He presents results of his work regularly at national and international dermatology, plastic surgical, and cosmetic meetings. Dr. Gold has authored over 500 published scientific articles, 40 textbook chapters, has edited two textbooks on Photodynamic Therapy as well as been Senior Editor on textbooks on Microneedling as well as Cosmeceuticals & Skin Care. He serves on most major dermatology journal scientific boards and is the current Editor-in-Chief of the Journal of Cosmetic Dermatology and the Editor-in-Chief of Dermatological Reviews. In addition, Dr. Gold helped establish the SCALE meeting in Nashville – now entering its 18th year - it is one of the leading U.S. dermatologic and aesthetic meetings. Dr. Gold also helped start two international groups: the Dermatologic Aesthetic Surgery International League (DASIL), which aims to create a global community for the open exchange of knowledge and innovation by physicians specializing in dermatology, dermatologic surgery, and aesthetic surgery. It has become one of the most prominent and important international dermatology groups. It show cases meetings all over the world; and the 5-Continent-Congress (5CC), one of the world’s leading conferences on dermatology and aesthetic/cosmetic medicine, where he is the current President of the Congress and has overseen the growth of this meeting since its inception 13 years ago.